AMBIEN CR
Pronunciation: ZOL-pi-dem (AM-bee-un)


What it isControlled-release GABA-A positive modulator; insomnia involving sleep onset and maintenance.
Why this oneIts biphasic tablet (outer layer for onset, core for maintenance) is labeled for sleep-maintenance insomnia, unlike IR.
What limits itBoxed complex sleep behaviors can occur after any exposure; next-day impairment, falls, and dependence also matter.
Animated chart of estimated U.S. prescriptions per year, Sleep meds (1869–2026). Zolpidem CR enters in 1993 (estimated).
Legacy pregnancy categoryC
Defining liabilityComplex sleep behaviors, next-day impairment, falls and additive CNS depression.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Short-term treatment of insomnia (sleep onset and/or maintenance) | Adults | 6.25 mg QHS (women); 6.25 or 12.5 mg QHS (men) | 12.5 mg QD | |
| Short-term treatment of insomnia | Geriatric/debilitated or mild–moderate hepatic impairment | 6.25 mg QHS | 6.25 mg QD |
Renal Undefined
Hepatic Mild–moderate: 6.25 mg QHS. Avoid in severe hepatic impairment (may precipitate encephalopathy).
Single dose per night; do not readminister during the same night
Available strengths
Pregnancy Late third-trimester use may cause neonatal respiratory depression and sedation.
Lactation May pump and discard breast milk during treatment and for 23 h after a dose.
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 6.25 mg | ER tab | 30 qd | $3.05 | not offered |
| 12.5 mg | ER tab | 30 qd | $3.28 | not offered |
Other forms: Zolpidem (AMBIEN) · Zolpidem SL (EDLUAR)
Open Zolpidem CR in the interactive console ↗

Open Zolpidem CR in the interactive console ↗